1. Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis. (2nd June 2020) Authors: Hansen, B. B.; Nuhoho, S.; Ali, S. N.; Dang-Tan, T.; Valentine, W. J.; Malkin, S. J. P.; Hunt, B. Journal: Journal of medical economics Issue: Volume 23:Number 6(2020) Page Start: 650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗